Background Background Few randomised
Few randomised controlled trials have been aimed controlled trials have been aimed specifically at substance use reduction specifically at substance use reduction among people with psychotic disorders. among people with psychotic disorders.
Aims
Aims To investigate whether a 10 -To investigate whether a 10 -session intervention consisting of session intervention consisting of motivational interviewing and cognitivemotivational interviewing and cognitiveb ehavioural therapy (CBT) was more behavioural therapy (CBT) was more efficacious than routine treatment in efficacious than routine treatment in reducing substance use and improving reducing substance use and improving symptomatology and general functioning. symptomatology and general functioning.
Method
Method A community sample of A community sample of people with a psychotic disorder and who people with a psychotic disorder and who reported hazardous alcohol, cannabis reported hazardous alcohol, cannabis and/or amphetamine use during the and/or amphetamine use during the preceding month was recruited. preceding month was recruited. Participants were randomly allocated to Participants were randomly allocated to motivational interviewing/CBT ( motivational interviewing/CBT (n n¼65) or 65) or treatment as usual ( treatment as usual (n n¼65), and were 65), and were assessed on multiple outcomes at baseline, assessed on multiple outcomes at baseline, 15 weeks, 6 months and12 months. 15 weeks, 6 months and12 months.
Results

Results There was a short-term
There was a short-term improvement in depression and a similar improvement in depression and a similar trend with regard to cannabis use among trend with regard to cannabis use among participants who received the participants who received the motivational interviewing/CBT motivational interviewing/CBT intervention, together with effects on intervention, together with effects on general functioning at12 months.There general functioning at12 months.There was no differential benefit of the was no differential benefit of the intervention on substance use at12 intervention on substance use at12 months, except for a potentially clinically months, except for a potentially clinically important effect on amphetamine use. important effect on amphetamine use.
Conclusions Conclusions The motivational
The motivational interviewing/CBT intervention was interviewing/CBT intervention was associated with modest improvements. associated with modest improvements.
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Few randomised controlled trials (RCTs) Few randomised controlled trials (RCTs) have been targeted at reducing substance use have been targeted at reducing substance use among people with psychotic disorders. among people with psychotic disorders. Two large RCTs have reported encouraging Two large RCTs have reported encouraging but short-term effects of single-session motibut short-term effects of single-session motivational interventions among psychiatric hosvational interventions among psychiatric hospital in-patients with mixed diagnoses and pital in-patients with mixed diagnoses and coexisting alcohol and/or other drug use coexisting alcohol and/or other drug use problems (Baker problems (Baker et al et al, 2002; Hulse & Tait, , 2002; Hulse & Tait, 2003) . In a pilot study of 25 in-patients with 2003). In a pilot study of 25 in-patients with early psychosis, Kavanagh early psychosis, Kavanagh et al et al (2004 Kavanagh et al et al ( ) (2004 reported that a total of 3 hours' motivational reported that a total of 3 hours' motivational interviewing resulted in significantly better interviewing resulted in significantly better outcomes. Cognitive-behavioural therapy outcomes. Cognitive-behavioural therapy (CBT) has been shown to be effective for pro-(CBT) has been shown to be effective for problems associated with alcohol (Shand blems associated with alcohol (Shand et al et al, , 2003) , cannabis (Copeland 2003) , cannabis (Copeland et al et al, 2001) and , 2001 ) and amphetamine use (Baker amphetamine use (Baker et al et al, 2005 , 2005a a), for im-), for improving psychotic symptomatology (Hadproving psychotic symptomatology (Haddock dock et al et al, 2003) and in related service , 2003) and in related service contexts (Graham contexts (Graham et al et al, 2004) . In the first , 2004). In the first RCT to investigate the efficacy of CBT among RCT to investigate the efficacy of CBT among people with coexisting schizophrenia and people with coexisting schizophrenia and substance use disorder, Barrowclough substance use disorder, Barrowclough et al et al (2001) reported modest yet promising find- (2001) reported modest yet promising findings. Eighteen months after study entry, the ings. Eighteen months after study entry, the treatment group had superior general functreatment group had superior general functioning and negative symptom scores, but tioning and negative symptom scores, but there was no differential effect on percentage there was no differential effect on percentage of days of abstinence from substances of days of abstinence from substances (Haddock (Haddock et al et al, 2003) . The authors suggested , 2003) . The authors suggested that larger studies are required that examine that larger studies are required that examine the efficacy of the different components of the efficacy of the different components of CBT interventions. The aim of the present CBT interventions. The aim of the present study was to investigate whether a 10-session study was to investigate whether a 10-session motivational motivational interviewing/CBT intervention interviewing/CBT intervention administered administered to a relatively large sample to a relatively large sample of people with psychosis and substance of people with psychosis and substance use disorders was more efficacious than use disorders was more efficacious than routine treatment in reducing substance routine treatment in reducing substance use and improving symptomatology and use and improving symptomatology and general functioning. general functioning.
METHOD METHOD Design Design
In the current RCT, all of the participants In the current RCT, all of the participants provided written informed consent and provided written informed consent and were assessed at baseline (pre-treatment), were assessed at baseline (pre-treatment), 15 weeks (post-treatment), 6 months and 15 weeks (post-treatment), 6 months and 12 months after the initial assessment. Par-12 months after the initial assessment. Participants were randomly allocated to one of ticipants were randomly allocated to one of the following two groups: the treatment the following two groups: the treatment group, which received 10 1-hour sessions group, which received 10 1-hour sessions of motivational interviewing and CBT (in of motivational interviewing and CBT (in addition to an assessment schedule, treataddition to an assessment schedule, treatment as usual and provision of self-help ment as usual and provision of self-help material for substance use); or the control material for substance use); or the control group, which received self-help material group, which received self-help material for substance use, treatment as usual, and for substance use, treatment as usual, and the same assessment schedule as that for the same assessment schedule as that for the treatment group. After the initial the treatment group. After the initial assessment, participants drew a card from assessment, participants drew a card from an envelope, which allocated them to an envelope, which allocated them to either the treatment group or the control either the treatment group or the control group. group.
Participants Participants
The study participants were 130 regular The study participants were 130 regular users of alcohol, cannabis and/or amphetausers of alcohol, cannabis and/or amphetamines who had a non-acute psychotic mines who had a non-acute psychotic disorder, and who were recruited from the disorder, and who were recruited from the Hunter region, 150 kilometres north of Hunter region, 150 kilometres north of Sydney, New South Wales, Australia. SubSydney, New South Wales, Australia. Substance use intervention thresholds included stance use intervention thresholds included alcohol consumption exceeding National alcohol consumption exceeding National Health and Medical Research Council Health and Medical Research Council (NHMRC) recommended levels (an aver-(NHMRC) recommended levels (an average of four standard drinks per day for age of four standard drinks per day for men and two standard drinks per day for men and two standard drinks per day for women) (Pols & Hawks, 1992) or at least women) (Pols & Hawks, 1992) or at least weekly use of cannabis or amphetamines weekly use of cannabis or amphetamines as recorded on the Opiate Treatment Index as recorded on the Opiate Treatment Index (OTI; Darke (OTI; Darke et al et al, 1991) for the month be-, 1991) for the month before the initial assessment. Other inclusion fore the initial assessment. Other inclusion criteria were as follows: age at least 15 criteria were as follows: age at least 15 years; ability to speak English; and having years; ability to speak English; and having a confirmed ICD-10 psychotic disorder a confirmed ICD-10 psychotic disorder (World Health Organization, 1992) . Exclu-(World Health Organization, 1992) . Exclusion criteria were: failure to meet at least sion criteria were: failure to meet at least one of the specified substance use threshone of the specified substance use thresholds; having an organic brain impairment; olds; having an organic brain impairment; and intending to move from the geographiand intending to move from the geographical area within the subsequent 12 months. cal area within the subsequent 12 months. Referrals to the present study were received Referrals to the present study were received from community health agencies (33.8%), from community health agencies (33.8%), in-patient psychiatric hospital units in-patient psychiatric hospital units (33.1%), an early psychosis service (33.1%), an early psychosis service (27.7%), media advertisements (3.1%) (27.7%), media advertisements (3.1%) and the Neuroscience Institute of Schizoand the Neuroscience Institute of Schizophrenia and Allied Disorders (NISAD; phrenia and Allied Disorders (NISAD; (Loughland (Loughland et al et al, 2001 ) Schizophrenia Re-, 2001) Schizophrenia Research Register (2.3%). Participants who search Register (2.3%). Participants who were initially approached via in-patient were initially approached via in-patient units were recontacted 2 months after disunits were recontacted 2 months after discharge and invited to participate in the charge and invited to participate in the study. study.
Procedure Procedure
All of the participants read an information All of the participants read an information sheet before giving their written consent sheet before giving their written consent to participate in the study. Parental/ to participate in the study. Parental/ guardian consent was sought for individguardian consent was sought for individuals under 18 years of age. Participants uals under 18 years of age. Participants were informed that they would be ranwere informed that they would be randomly assigned to one of two conditions. domly assigned to one of two conditions. Each participant was reimbursed with a Each participant was reimbursed with a Aus$20 fee for their time, travel and parAus$20 fee for their time, travel and participation at each assessment (but not for ticipation at each assessment (but not for treatment sessions). This amount was treatment sessions). This amount was considered small enough not to influence considered small enough not to influence participants' responses unduly, but suffiparticipants' responses unduly, but sufficient to reduce non-adherence caused by cient to reduce non-adherence caused by the inconvenience of attending assessment the inconvenience of attending assessment sessions. If possible, treatment sessions sessions. If possible, treatment sessions were conducted at the research centre or a were conducted at the research centre or a community clinic. However, if participants community clinic. However, if participants were unable to attend these centres, were unable to attend these centres, sessions were conducted in the participant's sessions were conducted in the participant's home. Any participant who missed three home. Any participant who missed three consecutive treatment sessions was considconsecutive treatment sessions was considered to have dropped out of treatment. ered to have dropped out of treatment. Follow-up assessments were conducted by Follow-up assessments were conducted by clinical interviewers who were masked to clinical interviewers who were masked to intervention status. intervention status.
Measures Measures
Key demographic and clinical characterisKey demographic and clinical characteristics and outcome measures are reported in tics and outcome measures are reported in this paper. The assessment instruments that this paper. The assessment instruments that were used have been reported previously were used have been reported previously (Baker (Baker et al et al, 2005 (Baker et al et al, , 2005b , and are described only ), and are described only briefly here. Data were collected on various briefly here. Data were collected on various demographic characteristics, treatment hisdemographic characteristics, treatment history (mental health and alcohol and/or tory (mental health and alcohol and/or other drug use) and current substance use. other drug use) and current substance use. Diagnosis in accordance with the ICD-10 Diagnosis in accordance with the ICD-10 was achieved by administering the Diagnoswas achieved by administering the Diagnostic Interview for Psychosis (DIP; Jablensky tic Interview for Psychosis (DIP; Jablensky et al et al, 2000) and applying the Operational , 2000) and applying the Operational Criteria for Psychosis (OPCRIT; McGuffin Criteria for Psychosis (OPCRIT; McGuffin et al et al, 1991) . The diagnosis obtained from , 1991). The diagnosis obtained from this interview were later collapsed to match this interview were later collapsed to match the psychosis categories reported in the the psychosis categories reported in the Low Prevalence Disorders Study (LPDS) Low Prevalence Disorders Study (LPDS) of the National Survey of Mental Health of the National Survey of Mental Health and Wellbeing (NSMHWB) (Jablensky and Wellbeing (NSMHWB) (Jablensky et et al al, 2000) , which are as follows: severe , 2000), which are as follows: severe depression with psychosis (F32.3); bipolar, depression with psychosis (F32.3); bipolar, mania (F30, F31); schizophrenia (F20); mania (F30, F31); schizophrenia (F20); schizoaffective disorder (F25); and other schizoaffective disorder (F25); and other psychosis (F22, F28, F29). psychosis (F22, F28, F29).
The Drug Use Scale of the OTI (Darke The Drug Use Scale of the OTI (Darke et al et al, 1991 (Darke et al et al, , 1992 , which was the primary , 1991, 1992), which was the primary measure of alcohol and/or other drug use, measure of alcohol and/or other drug use, was administered at each assessment. The was administered at each assessment. The OTI yields an average daily consumption OTI yields an average daily consumption score for 11 classes of drug during the score for 11 classes of drug during the month (28 days) before interview, with month (28 days) before interview, with weekly use of a single dose of cannabis or weekly use of a single dose of cannabis or amphetamines being equivalent to an OTI amphetamines being equivalent to an OTI score of 0.14 (4/28). The OTI also provides score of 0.14 (4/28). The OTI also provides a poly-drug use score which identifies the a poly-drug use score which identifies the number of drug classes used that month. In number of drug classes used that month. In addition, an aggregate substance use index addition, an aggregate substance use index score was used as a global measure to descore was used as a global measure to describe the number of 'day equivalents' of scribe the number of 'day equivalents' of hazardous use. This was necessary because hazardous use. This was necessary because the substance use measures varied with the substance use measures varied with regard to the units recorded (e.g. number of regard to the units recorded (e.g. number of standard drinks standard drinks v.
v. number of occasions of number of occasions of cannabis use). For each illicit substance the cannabis use). For each illicit substance the estimated number of days of consumption estimated number of days of consumption during the past 28 days was determined, during the past 28 days was determined, and for alcohol the number of days on which and for alcohol the number of days on which consumption exceeded consumption exceeded NHMRC recom-NHMRC recommended levels was calculated. Ten substances mended levels was calculated. Ten substances (excluding nicotine) (excluding nicotine) were included in the agwere included in the aggregate index. Thus it was theoretically possgregate index. Thus it was theoretically possible to have a score ranging from 0 day ible to have a score ranging from 0 day equivalents to 280 day equivalents. The equivalents to 280 day equivalents. The sections on alcohol use disorders and nonsections on alcohol use disorders and nonalcohol psychoactive substance use disorders alcohol psychoactive substance use disorders in the Structured Clinical Interview for in the Structured Clinical Interview for DSM-IV Axis I Disorders -Research Ver-DSM-IV Axis I Disorders -Research Version (SCID-I-RV; First sion (SCID-I-RV; First et al et al, 2003 First et al et al, ) were , 2003 were also used at the baseline assessment and at also used at the baseline assessment and at the 6-and 12-month follow-ups to deterthe 6-and 12-month follow-ups to determine current and lifetime substance misuse mine current and lifetime substance misuse or dependence, as well as that during the or dependence, as well as that during the past 12 months. A modified version of the past 12 months. A modified version of the Readiness to Change Questionnaire Readiness to Change Questionnaire (RCQ; Heather & Rollnick, 1993) was (RCQ; Heather & Rollnick, 1993) was used to assess stage of change with regard used to assess stage of change with regard to alcohol, cannabis and amphetamines. to alcohol, cannabis and amphetamines.
Psychiatric symptomatology was Psychiatric symptomatology was assessed using the Brief Psychiatric Rating assessed using the Brief Psychiatric Rating Scale (BPRS; Ventura Scale (BPRS; Ventura et al et al, 1993 Ventura et al et al, ), which , 1993 , which was also administered at each assessment was also administered at each assessment time point. Thomas time point. Thomas et al et al (2004) have (2004) have recently reviewed the published factor anarecently reviewed the published factor analyses of the 24-item BPRS and undertaken a lyses of the 24-item BPRS and undertaken a two-tiered analysis (exploratory and confirtwo-tiered analysis (exploratory and confirmatory factor analyses) of BPRS data from matory factor analyses) of BPRS data from 640 psychiatric in-patients. Unfortunately, 640 psychiatric in-patients. Unfortunately, their four-factor solution effectively distheir four-factor solution effectively discarded over a third of the items (9/24), carded over a third of the items (9/24), many of which have reasonably consistent many of which have reasonably consistent loadings in earlier studies and also loadings in earlier studies and also according to Ventura according to Ventura et al et al (2000) . In the (2000) . In the interests of finding a more parsimonious interests of finding a more parsimonious solution, we factor-analysed the 1531 sets solution, we factor-analysed the 1531 sets of BPRS ratings that were collected as part of BPRS ratings that were collected as part of the present study and a concurrent treatof the present study and a concurrent treatment study of smokers with a psychotic disment study of smokers with a psychotic disorder (Baker order (Baker et al et al, 2005 (Baker et al et al, , 2005b , giving a total of ), giving a total of 427 participants who were assessed at 427 participants who were assessed at baseline and on up to three follow-up baseline and on up to three follow-up occasions. The solution that was extracted, occasions. The solution that was extracted, based on a principal-components analysis based on a principal-components analysis with an oblique rotation, resulted in the with an oblique rotation, resulted in the assignment of five items to each of four assignment of five items to each of four factors (with scores in the range 5-35 for factors (with scores in the range 5-35 for each factor) as follows: factor 1, mania each factor) as follows: factor 1, mania (motor hyperactivity, excitement, tension, (motor hyperactivity, excitement, tension, distractibility, elevated mood); factor 2, distractibility, elevated mood); factor 2, dysphoria (depression, guilt, anxiety, dysphoria (depression, guilt, anxiety, suicidality, somatic concern); factor 3, suicidality, somatic concern); factor 3, negative symptoms (blunted affect, emonegative symptoms (blunted affect, emotional withdrawal, motor retardation, distional withdrawal, motor retardation, disorientation, self-neglect); and factor 4, orientation, self-neglect); and factor 4, positive symptoms (unusual thought conpositive symptoms (unusual thought content, grandiosity, hallucinations, bizarre tent, grandiosity, hallucinations, bizarre behaviour, suspiciousness). These factors behaviour, suspiciousness , 1988, 1996) was also employed to measure 1988, 1996) was also employed to measure severity of depression during the past 2 severity of depression during the past 2 weeks, and the Global Assessment of Funcweeks, and the Global Assessment of Functioning (GAF; American Psychiatric tioning (GAF; American Psychiatric Association, 1994) was used to measure Association, 1994) was used to measure overall functioning. On all scales that overall functioning. On all scales that measure alcohol and/or other drug use measure alcohol and/or other drug use and psychiatric symptomatology, higher and psychiatric symptomatology, higher scores indicate poorer functioning, except scores indicate poorer functioning, except for the GAF, in which higher scores for the GAF, in which higher scores indicate better functioning. indicate better functioning.
Components of the intervention Components of the intervention
The treatment was manualised (Baker The treatment was manualised (Baker et al et al, , 2004 ) and consisted of 10 weekly, 1-hour 2004) and consisted of 10 weekly, 1-hour sessions (motivational interviewing in sessessions (motivational interviewing in sessions 1 to 4 and CBT in sessions 5 to 10), sions 1 to 4 and CBT in sessions 5 to 10), with the last two sessions concentrating with the last two sessions concentrating on relapse prevention for substance use on relapse prevention for substance use and mental health problems. A treatment and mental health problems. A treatment contract was established early in the intercontract was established early in the intervention, and this outlined both therapist vention, and this outlined both therapist and participant expectations. A therapist and participant expectations. A therapist checklist, adapted from the National Instichecklist, adapted from the National Institute on Drug Abuse (Schuster, 1989) , was tute on Drug Abuse (Schuster, 1989) , was completed at the end of each treatment completed at the end of each treatment session to monitor therapist adherence to session to monitor therapist adherence to core treatment components. The three core treatment components. The three therapists were state-registered psycholotherapists were state-registered psychologists with a minimum of 2 years' postgists with a minimum of 2 years' postgraduate clinical training, who received graduate clinical training, who received training and weekly clinical supervision training and weekly clinical supervision from A.B. from A.B.
Motivational interviewing Motivational interviewing
Treatment sessions commenced with Treatment sessions commenced with motivational interviewing the week after motivational interviewing the week after the baseline assessment. The therapists the baseline assessment. The therapists followed the four general principles outfollowed the four general principles outlined by Miller & Rollnick (2002) , namely lined by Miller & Rollnick (2002) , namely expressing empathy, developing discreexpressing empathy, developing discrepancy, rolling with resistance and supportpancy, rolling with resistance and supporting self-efficacy. Feedback was given with ing self-efficacy. Feedback was given with regard to current levels of alcohol and/or regard to current levels of alcohol and/or other drug use and the possible interaction other drug use and the possible interaction with symptoms. Information was delivered with symptoms. Information was delivered interactively with regard to current subinteractively with regard to current substance use and safer consumption levels, stance use and safer consumption levels, covering each problematic substance used covering each problematic substance used (except for nicotine). Participants were (except for nicotine). Participants were asked to complete self-monitoring records asked to complete self-monitoring records (Jarvis (Jarvis et al et al, 1995) of their symptoms and , 1995) of their symptoms and alcohol and/or other drug use to prepare alcohol and/or other drug use to prepare them for the subsequent transition to them for the subsequent transition to CBT. Therapists also completed a case for-CBT. Therapists also completed a case formulation sheet in collaboration with the mulation sheet in collaboration with the participant. When a participant had participant. When a participant had demonstrated that they had arrived at the demonstrated that they had arrived at the 'determination' or 'action' stage of change 'determination' or 'action' stage of change (Prochaska & DiClemente, 1986) , the (Prochaska & DiClemente, 1986) , the cognitive-behavioural component of the cognitive-behavioural component of the intervention commenced. intervention commenced.
CBT CBT
An agenda was set at the beginning of each An agenda was set at the beginning of each session, and homework from the previous session, and homework from the previous week's session was reviewed before contiweek's session was reviewed before continuing with the CBT goals for that session. nuing with the CBT goals for that session. The material that was covered during The material that was covered during sessions was applied flexibly according to sessions was applied flexibly according to the needs of each individual, and included the needs of each individual, and included the following: presenting the rationale for the following: presenting the rationale for CBT and the process of therapy; the cogni-CBT and the process of therapy; the cognitive model of problematic substance use tive model of problematic substance use and psychotic symptoms (Graham and psychotic symptoms (Graham et al et al, , 2004) ; specific techniques for managing 2004); specific techniques for managing alcohol and/or other drug use and sympalcohol and/or other drug use and symptoms more effectively; and identification toms more effectively; and identification of situational triggers and beliefs that could of situational triggers and beliefs that could lead to substance use and exacerbation of lead to substance use and exacerbation of psychotic symptoms (Jarvis psychotic symptoms (Jarvis et al et al, 1995; , 1995; Graham Graham et al et al, 2004) . Finally, the identifica-, 2004). Finally, the identification and avoidance of high-risk situations tion and avoidance of high-risk situations (Monti (Monti et al et al, 1989) that could lead to , 1989) that could lead to maintenance of substance use were exmaintenance of substance use were explored, and various coping strategies were plored, and various coping strategies were practised in the form of role-plays. Other practised in the form of role-plays. Other topics included the following: discussion topics included the following: discussion of seemingly irrelevant decisions (Monti of seemingly irrelevant decisions (Monti et et al al, 1989) ; problem-solving strategies (Jarvis , 1989) ; problem-solving strategies (Jarvis et al et al, 1995) ; identification and management , 1995); identification and management of 'unhelpful' patterns of thinking (Graham of 'unhelpful' patterns of thinking (Graham et al et al, 2004) ; management of cravings, the , 2004); management of cravings, the abstinence/rule violation effect and drink/ abstinence/rule violation effect and drink/ drug refusal skills (Monti drug refusal skills (Monti et al et al, 1989); and , 1989) ; and lifestyle issues. The final two sessions lifestyle issues. The final two sessions focused on strategies for relapse prevention focused on strategies for relapse prevention (Marlatt & Gordon, 1998) . (Marlatt & Gordon, 1998) .
Treatment as usual Treatment as usual
Participants were informed that they were Participants were informed that they were using substances at above the recomusing substances at above the recommended levels. They received a self-help mended levels. They received a self-help booklet on substance use (Centre for booklet on substance use (Centre for Education and Information on Drugs and Education and Information on Drugs and Alcohol, 2000) , and were encouraged to Alcohol, 2000) , and were encouraged to maintain or increase their contact with maintain or increase their contact with local health services. local health services.
Statistical analysis Statistical analysis
Data were analysed using SPSS for WinData were analysed using SPSS for Windows (version 12.0). For the continuous dows (version 12.0). For the continuous outcome variables (e.g. alcohol, cannabis, outcome variables (e.g. alcohol, cannabis, amphetamine use), analysis of variance amphetamine use), analysis of variance (ANOVA)-based planned comparisons (ANOVA)-based planned comparisons were used to examine differences between were used to examine differences between groups and patterns of change across groups and patterns of change across assessment time points. Categorical variassessment time points. Categorical variables were analysed using chi-squared tests. ables were analysed using chi-squared tests. As a partial control for the number of As a partial control for the number of statistical tests, the threshold for signifistatistical tests, the threshold for significance was set at cance was set at P P5 50.01. 0.01.
RESULTS RESULTS
Baseline characteristics Baseline characteristics of participants of participants
Overall recruitment and attrition profiles Overall recruitment and attrition profiles are presented in Fig Of those individuals who met the intervention threshold criteria for alcohol intervention threshold criteria for alcohol use at baseline, 37.7% were at the preuse at baseline, 37.7% were at the precontemplation stage of change and 26.4% contemplation stage of change and 26.4% were at the contemplation stage, based on were at the contemplation stage, based on responses to the RCQ (Heather & Rollnick, responses to the RCQ (Heather & Rollnick, 1993) . The corresponding baseline rates for 1993). The corresponding baseline rates for the other substances indicated somewhat the other substances indicated somewhat higher levels of motivation to change higher levels of motivation to change (cannabis: pre-contemplation, 25.0%; (cannabis: pre-contemplation, 25.0%; contemplation, 48.8%; amphetamine: contemplation, 48.8%; amphetamine: pre-contemplation, 13.6%; contemplation, pre-contemplation, 13.6%; contemplation, 50.0%). 50.0%).
The demographic and clinical characThe demographic and clinical characteristics of the participants who completed teristics of the participants who completed the first three assessments ( the first three assessments (n n¼119) are 119) are shown in Table 1 (58 treatment group shown in Table 1 (58 treatment group and 61 control group participants). The and 61 control group participants). The mean age was 28.83 years and the majority mean age was 28.83 years and the majority of the participants in the sample were male of the participants in the sample were male (78.2%), born in Australia (90.8%), single (78.2%), born in Australia (90.8%), single (78.2%) and receiving welfare support (78.2%) and receiving welfare support (88.2%). Schizophrenia was the primary (88.2%). Schizophrenia was the primary diagnosis (62.2%), and the majority of the diagnosis (62.2%), and the majority of the sample met the criteria for lifetime or past sample met the criteria for lifetime or past 12 months' alcohol and cannabis misuse 12 months' alcohol and cannabis misuse or dependence, whereas 42.0% of the samor dependence, whereas 42.0% of the sample reported amphetamine misuse or depenple reported amphetamine misuse or dependence in the past 12 months. The dence in the past 12 months. The intervention thresholds for current subintervention thresholds for current substance use were met by 43.7% for alcohol stance use were met by 43.7% for alcohol (treatment group, 21/58; control group (treatment group, 21/58; control group 31/61), 61.3% for cannabis (treatment 31/61), 61.3% for cannabis (treatment group, 39/58; control group, 34/61) and group, 39/58; control group, 34/61) and 16.8% for amphetamine (treatment group, 16.8% for amphetamine (treatment group, 11/58; control group, 9/61). More than half 11/58; control group, 9/61). More than half 4 4 1 4 4 1 of the sample had experienced a psychosoof the sample had experienced a psychosocial stressor before the onset of their disorcial stressor before the onset of their disorder. The majority of the participants der. ) and 6-month (94.6%) follow-up, with the lowest participation rate low-up, with the lowest participation rate occurring at the 12-month follow-up occurring at the 12-month follow-up (80.0%), although attendance levels still (80.0%), although attendance levels still remained high. Two separate data-sets were remained high. Two separate data-sets were established to take into account these difestablished to take into account these different patterns of follow-up, namely partiferent patterns of follow-up, namely participants who completed the baseline, 15-cipants who completed the baseline, 15-week and 6-month assessments ( week and 6-month assessments (n n¼119, 119, 91.5%), and participants who completed 91.5%), and participants who completed all four assessments ( all four assessments (n n¼97, 74.6%). There 97, 74.6%). There were no significant differences between were no significant differences between groups in the pattern of completion of groups in the pattern of completion of follow-up. In the analyses which follow, follow-up. In the analyses which follow, planned comparisons between the first planned comparisons between the first three assessments were based on the first three assessments were based on the first block ( block (n n¼119), whereas comparisons 119), whereas comparisons between the final assessment and each of between the final assessment and each of the earlier assessments were based on the the earlier assessments were based on the second block ( second block (n n¼97). 97).
Changes in substance use Changes in substance use
Mean baseline, 15-week, 6-month and 12-Mean baseline, 15-week, 6-month and 12-month follow-up scores for the key month follow-up scores for the key substances are shown in Table 2 for substances are shown in Table 2 for participants who were above the relevant participants who were above the relevant substance use thresholds at baseline, substance use thresholds at baseline, together with standardised differences (in together with standardised differences (in effect size units) between baseline and the effect size units) between baseline and the 12 month follow-up. It can be seen that 12 month follow-up. It can be seen that there were significant time effects for alcothere were significant time effects for alcohol, poly-drug use and the aggregate hazarhol, poly-drug use and the aggregate hazardous use index, but there were no group dous use index, but there were no group 4 4 2 4 4 2 main effects or group main effects or group6 6time interactions. time interactions. Alcohol consumption decreased signifiAlcohol consumption decreased significantly for the sample as a whole, with the cantly for the sample as a whole, with the 15-week, 6-month and 12-month follow-15-week, 6-month and 12-month followup assessments all having lower OTI scores up assessments all having lower OTI scores than at baseline. The reduction in alcohol than at baseline. The reduction in alcohol consumption between baseline and the 12-consumption between baseline and the 12-month follow-up was equivalent to an month follow-up was equivalent to an overall effect size change of 0.80 units. This overall effect size change of 0.80 units. This difference tended to be more marked for difference tended to be more marked for the control group (0.97) than for the the control group (0.97) than for the treated group (0.54). treated group (0.54).
There were no significant time effects for There were no significant time effects for either cannabis or amphetamine use. For either cannabis or amphetamine use. For cannabis, there tended to be higher consumpcannabis, there tended to be higher consumption in the treatment group than in the contion in the treatment group than in the control group initially (8.18 trol group initially (8.18 v.
v. 4.80), and there 4.80), and there was a non-significant trend for a differential was a non-significant trend for a differential reduction in cannabis consumption between reduction in cannabis consumption between the baseline and 15-week assessments for the baseline and 15-week assessments for the treatment group compared with the conthe treatment group compared with the control group ( trol group (F F (1,71) ( (Table 2) . assessments (Table 2) .
For amphetamine, there was a nonFor amphetamine, there was a nonsignificant trend towards a differential significant trend towards a differential (baseline (baseline v.
v. 6 months) reduction in amphe-6 months) reduction in amphetamine use in the treatment group comtamine use in the treatment group compared with the control group ( pared with the control group (F F (1,18) (1,18) ¼4.70, 4.70, P P¼0.04). The mean daily number of occa-0.04). The mean daily number of occasions of amphetamine use fell by 1.33 sions of amphetamine use fell by 1.33 standardised units for the treatment group standardised units for the treatment group compared with compared with 7 70.40 for the control 0.40 for the control group, which represents a differential group, which represents a differential change of 1.73 standardised units (a large change of 1.73 standardised units (a large effect size). As is shown in Table 2 , this effect size). As is shown in Table 2 , this differential was less marked (0.95) for the differential was less marked (0.95) for the 12-month follow-up, but was still strong. 12-month follow-up, but was still strong.
Reflecting the significant reduction in alcoReflecting the significant reduction in alcohol hol use among the whole sample, and the use among the whole sample, and the trends towards a change in the level of trends towards a change in the level of amphetamine use, there was a significant amphetamine use, there was a significant overall reduction in poly-drug use scores over overall reduction in poly-drug use scores over time, with significant differences between time, with significant differences between baseline and each of the follow-up assessbaseline and each of the follow-up assessments (Table 2) . A similar pattern emerged ments (Table 2) . A similar pattern emerged for the aggregate substance use index. for the aggregate substance use index. Table 3 shows the percentage of partici- Table 3 shows the percentage of participants who remained above the alcohol, pants who remained above the alcohol, cannabis and amphetamine thresholds at cannabis and amphetamine thresholds at each follow-up assessment, and the correeach follow-up assessment, and the corresponding abstinence rates. There were no sponding abstinence rates. There were no significant group differences in threshold significant group differences in threshold rates or abstinence rates for any substance rates or abstinence rates for any substance at any of the follow-up assessments. at any of the follow-up assessments.
Changes in symptomatology Changes in symptomatology Table 4 shows the symptom profiles for the Table 4 shows the symptom profiles for the intervention and control groups, together intervention and control groups, together with standardised change scores between with standardised change scores between 4 4 3 4 4 3 3. There were no significant treatment 3. There were no significant treatment v. v. control differences (either main effects or interactions) for any substance. control differences (either main effects or interactions) for any substance. * *P P5 50.01, ** 0.01, **P P5 50.001. 0.001.
baseline and the 12 months follow-up. baseline and the 12 months follow-up.
There was a significant improvement There was a significant improvement between baseline and the 12-month between baseline and the 12-month assessment on the BPRS mania factor, and assessment on the BPRS mania factor, and between baseline and each of the followbetween baseline and each of the followup assessments on the BPRS negative sympup assessments on the BPRS negative symptoms factor. The overall standardised toms factor. The overall standardised change in BPRS negative symptoms bechange in BPRS negative symptoms between baseline and the 12-month assesstween baseline and the 12-month assessment was around half a standard ment was around half a standard deviation. There were no other significant deviation. There were no other significant effects for the BPRS scales (i.e. for dyseffects for the BPRS scales (i.e. for dysphoria, positive symptoms or BPRS total phoria, positive symptoms or BPRS total scores). BDI-II depression scores were also scores). BDI-II depression scores were also significantly lower at each of the followsignificantly lower at each of the followup assessments than at baseline, with a up assessments than at baseline, with a more marked reduction between baseline more marked reduction between baseline and the 6-month assessment for the interand the 6-month assessment for the intervention group than for the control group vention group than for the control group (0.78 (0.78 v. v. 0.28 standardised units, or a half 0.28 standardised units, or a half a standard deviation of differential impact). a standard deviation of differential impact). Although there were no main effects in the Although there were no main effects in the GAF analyses, there was a significant GAF analyses, there was a significant group group6 6time interaction, with a deterioratime interaction, with a deterioration in global functioning between baseline tion in global functioning between baseline and the 12-month assessment for the conand the 12-month assessment for the control group, and a small improvement in trol group, and a small improvement in the treatment group. This is reflected by the treatment group. This is reflected by the fact that the standardised change scores the fact that the standardised change scores for this variable were negative for the treatfor this variable were negative for the treatment group, indicating an improvement in ment group, indicating an improvement in functioning. Thus the decrease of functioning. Thus the decrease of 7 70.15 0.15 units in the treatment group compared with units in the treatment group compared with 0.43 in the control group represents a 0.43 in the control group represents a differential impact of over half a standard differential impact of over half a standard deviation (0.58) (a moderate effect size). deviation (0.58) (a moderate effect size).
Intention-to-treat (ITT) analyses Intention-to-treat (ITT) analyses
A series of ITT analyses was also performed A series of ITT analyses was also performed that paralleled those shown in Tables 2 to  that paralleled those shown in Tables 2 to   4 . Reflecting the relatively low rate of attri-4. Reflecting the relatively low rate of attrition in this study (Fig. 1) , there were no tion in this study (Fig. 1) , there were no differences in the patterns of significance differences in the patterns of significance compared with those already reported. compared with those already reported. That is, all of the statistically significant That is, all of the statistically significant planned comparisons shown in Tables 2  planned comparisons shown in Tables 2  and 4 remained significant after imputation and 4 remained significant after imputation of missing data, and there were no addiof missing data, and there were no additional effects that reached significance. To tional effects that reached significance. To facilitate comparisons with other RCTs facilitate comparisons with other RCTs that have utilised ITT analyses, Tables 2  that have utilised ITT analyses, Tables 2  and 4 also show standardised differences and 4 also show standardised differences (in effect size units) between baseline and (in effect size units) between baseline and the 12-month assessment for the ITT the 12-month assessment for the ITT data-set. Similarly, Table 3 shows the data-set. Similarly, Table 3 shows the ITT-based abstinence rates for each of the ITT-based abstinence rates for each of the follow-up assessments. follow-up assessments.
DISCUSSION DISCUSSION
The present study appears to be the first The present study appears to be the first moderately sized RCT of a motivational moderately sized RCT of a motivational interviewing/CBT intervention for alcohol interviewing/CBT intervention for alcohol and/or other drug use in a sample of people and/or other drug use in a sample of people with psychosis. Collectively, there was little with psychosis. Collectively, there was little evidence of treatment-specific benefits, evidence of treatment-specific benefits, with no statistically significant differential with no statistically significant differential improvements in substance use at the improvements in substance use at the 12-month assessment (Table 2) , and no sig-12-month assessment (Table 2) , and no significant differences in abstinence rates nificant differences in abstinence rates between the treatment and control groups between the treatment and control groups (see Table 3 ). However, among those (see Table 3 ). However, among those individuals who received the motivational individuals who received the motivational interviewing/CBT intervention, there were interviewing/CBT intervention, there were short-term improvements in depression short-term improvements in depression (differential impact at 6 months (differential impact at 6 months¼0.50 0.50 standardised units), a similar but less standardised units), a similar but less marked trend with regard to cannabis use marked trend with regard to cannabis use (differential impact at 3 months (differential impact at 3 months¼0.38 0.38 standardised units), effects on general funcstandardised units), effects on general functioning (differential impact at 12 months tioning (differential impact at 12 months ¼0.58 standardised units) and a potentially 0.58 standardised units) and a potentially clinically important effect on amphetamine clinically important effect on amphetamine use (differential impact at 12 months use (differential impact at 12 months¼0.95 0.95 standardised units). As described below, standardised units). As described below, although the overall results of this 10-although the overall results of this 10-session intervention were modest, they were session intervention were modest, they were nevertheless similar to those obtained from nevertheless similar to those obtained from a longer and more complex intervention a longer and more complex intervention ) and the present study reported short-term benefits of intervention on short-term benefits of intervention on substance use. At pre-treatment, their motisubstance use. At pre-treatment, their motivational interviewing/CBT group had a vational interviewing/CBT group had a median of 19.1% of days on which there median of 19.1% of days on which there was abstinence from all substances, which was abstinence from all substances, which was approximately doubled during the was approximately doubled during the treatment and follow-up phases. Minimal treatment and follow-up phases. Minimal changes in substance use were reported changes in substance use were reported for the control group. In the present study, for the control group. In the present study, heavy users of cannabis appeared to benefit heavy users of cannabis appeared to benefit from the intervention while it was being adfrom the intervention while it was being administered, but cannabis use returned to the ministered, but cannabis use returned to the previous high levels once the intervention previous high levels once the intervention had been completed. There was also a had been completed. There was also a potentially clinically important treatment potentially clinically important treatment benefit with regard to amphetamine use. benefit with regard to amphetamine use. Although it was not statistically significant, Although it was not statistically significant, possibly owing to the small numbers of regpossibly owing to the small numbers of regular amphetamine users, the large effect ular amphetamine users, the large effect size associated with the intervention, size associated with the intervention, combined with previous evidence of the combined with previous evidence of the effectiveness of CBT among regular effectiveness of CBT among regular amphetamine users (Baker amphetamine users ( 1. Excludes participants who were below the relevant substance-use threshold at baseline. Data for 15 weeks and 6 months are for participants who completed the first three 1. Excludes participants who were below the relevant substance-use threshold at baseline. Data for 15 weeks and 6 months are for participants who completed the first three assessment phases, and data for 12 months are for participants who completed all four assessments.Values in square brackets are from comparable intention-to-treat analyses. assessment phases, and data for 12 months are for participants who completed all four assessments.Values in square brackets are from comparable intention-to-treat analyses.
2. There were no significant treatment 2. There were no significant treatment v. v. control differences for any phase. control differences for any phase.
suggests that further studies of CBT for suggests that further studies of CBT for people with psychotic and amphetamine people with psychotic and amphetamine use disorders are needed. However, caution use disorders are needed. However, caution needs to be exercised in relation to the curneeds to be exercised in relation to the current findings with regard to amphetamine rent findings with regard to amphetamine use, as the control group had a relatively use, as the control group had a relatively low baseline rate of use, and therefore less low baseline rate of use, and therefore less opportunity to demonstrate change, but opportunity to demonstrate change, but conversely they had the highest rate of abconversely they had the highest rate of abstinence at 12 months (see Tables 2 and 3 ). stinence at 12 months (see Tables 2 and 3) .
Treatment effects for current Treatment effects for current functioning and depression functioning and depression
Barrowclough and colleagues (BarrowBarrowclough and colleagues (Barrowclough clough et al et al, 2001; Haddock , 2001; Haddock et al et al, 2003) , 2003) selected the GAF as their primary outcome selected the GAF as their primary outcome measure, specifically to enable the detection measure, specifically to enable the detection of overall changes in symptoms and of overall changes in symptoms and functioning resulting from the interaction functioning resulting from the interaction between psychosis and substance use and between psychosis and substance use and the multi-component nature of their interthe multi-component nature of their intervention. Both their study and the present vention. Both their study and the present one reported a differential improvement in one reported a differential improvement in GAF scores (rated masked) at the final GAF scores (rated masked) at the final follow-up (12 months in the present study follow-up (12 months in the present study and 18 months in the study by Barrowand 18 months in the study by Barrowclough and colleagues, both of which clough and colleagues, both of which occurred 9 months after treatment). In the occurred 9 months after treatment). In the present study, this was primarily caused present study, this was primarily caused by a deterioration in GAF scores in the conby a deterioration in GAF scores in the control group, with a net change of 0.58 standtrol group, with a net change of 0.58 standardised units, whereas the net change of ardised units, whereas the net change of 0.76 units in the Barrowclough study was 0.76 units in the Barrowclough study was caused by the sustained superiority in caused by the sustained superiority in GAF scores for the CBT group. Two RCTs GAF scores for the CBT group. Two RCTs have shown that intervention consisting of have shown that intervention consisting of motivational interviewing and CBT for motivational interviewing and CBT for substance use problems in people with psysubstance use problems in people with psychosis can affect general functioning. A chosis can affect general functioning. A modest delayed beneficial effect of CBT modest delayed beneficial effect of CBT on GAF scores at 12 months has also been on GAF scores at 12 months has also been reported by Kemp reported by Kemp et al et al (1998) following a (1998) following a 'compliance-therapy' intervention. To help 'compliance-therapy' intervention. To help to clarify the relevance of these changes in to clarify the relevance of these changes in functioning, future studies of interventions functioning, future studies of interventions involving motivational interviewing and involving motivational interviewing and CBT should include the GAF, together with CBT should include the GAF, together with measures of symptomatology and submeasures of symptomatology and substance use. Haddock stance use. Haddock et al et al (2003) also (2003) also recommend that further trials should seek recommend that further trials should seek to identify the active and most important to identify the active and most important ingredients of successful therapy. ingredients of successful therapy.
As we have noted previously (Baker As we have noted previously (Baker et et al al, 2005 , 2005b b), the present sample had rela-), the present sample had relatively high levels of functioning. Their avertively high levels of functioning. Their average GAF score at baseline was 68.75 age GAF score at baseline was 68.75 (s.d. (s.d.¼12.80, 12.80, n n¼130) , which was approxi-130), which was approximately 33% higher than that reported in mately 33% higher than that reported in the Barrowclough study (Barrowclough the Barrowclough study (Barrowclough et et 4 4 5 4 4 5 1. Data for baseline, 15 weeks and 6 months are for participants who completed the first three assessment phases, and data for12 months are for participants who completed all four 1. Data for baseline, 15 weeks and 6 months are for participants who completed the first three assessment phases, and data for12 months are for participants who completed all four assessments. assessments. 2. Using as a reference point the grand standard deviation for the relevant variable (i.e. across all assessments).Values in square brackets are from comparable intention-to-treat 2. Using as a reference point the grand standard deviation for the relevant variable (i.e. across all assessments).Values in square brackets are from comparable intention-to-treat analyses. analyses. 3. For this variable, negative effect sizes indicate an improvement in functioning over time. 3. For this variable, negative effect sizes indicate an improvement in functioning over time. 4. There were no significant treatment 4. There were no significant treatment v. v. control main effects. control main effects. * *P P5 50.01, ** 0.01, **P P5 50.001. 0.001. , 2003) , and 85% higher than that reported by Kemp higher than that reported by Kemp et al et al (1998) for their in-patient study. Perhaps (1998) for their in-patient study. Perhaps people who present or are referred to people who present or are referred to community-based treatment studies are community-based treatment studies are generally better functioning than those generally better functioning than those who are recruited directly from mental who are recruited directly from mental health service settings. In any event, it health service settings. In any event, it may not be possible to generalise the outmay not be possible to generalise the outcomes of treatment studies that are based comes of treatment studies that are based on better functioning or more highly motion better functioning or more highly motivated samples to other treatment settings. vated samples to other treatment settings. Higher levels of functioning at baseline Higher levels of functioning at baseline may influence engagement with treatment may influence engagement with treatment and retention, but may also make it more and retention, but may also make it more difficult to detect particular treatment difficult to detect particular treatment benefits. For example, higher-functioning benefits. For example, higher-functioning individuals with coexisting psychotic and individuals with coexisting psychotic and alcohol use disorders may respond posialcohol use disorders may respond positively to the assessment process and to tively to the assessment process and to advice to reduce substance use, within the advice to reduce substance use, within the context of ongoing monitoring. , 2003) also reported significant benefits of interalso reported significant benefits of intervention compared with routine care at the vention compared with routine care at the 12-month follow-up with regard to positive 12-month follow-up with regard to positive symptoms and relapse rates, and at the 9-, symptoms and relapse rates, and at the 9-, 12-and 18-month follow-up with regard 12-and 18-month follow-up with regard to negative symptoms. As noted previously, to negative symptoms. As noted previously, there was a relatively low rate of psychotic there was a relatively low rate of psychotic symptoms in the sample in the present symptoms in the sample in the present study (Baker study (Baker et al et al, 2005 (Baker et al et al, , 2005b . There was a ). There was a reduction in negative symptoms (and to a reduction in negative symptoms (and to a lesser extent in mania scores) across the lesser extent in mania scores) across the sample as a whole in this study. The obsample as a whole in this study. The observed initial improvement in depression served initial improvement in depression in the treatment group is likely to have been in the treatment group is likely to have been a result of either the generalisation of a result of either the generalisation of cognitive and behavioural strategies for cognitive and behavioural strategies for substance use to low mood, or the nonsubstance use to low mood, or the nonspecific support received when attending specific support received when attending therapy sessions. The possible non-specific therapy sessions. The possible non-specific effect of CBT for substance use on effect of CBT for substance use on depression has previously been noted by depression has previously been noted by us in a study of regular amphetamine users us in a study of regular amphetamine users (Baker (Baker et al et al, 2005 (Baker et al et al, , 2005a . Thus it appears that ). Thus it appears that people with concurrent depression and subpeople with concurrent depression and substance use disorders (whether or not these stance use disorders (whether or not these are accompanied by psychosis) may derive are accompanied by psychosis) may derive at least short-term benefits in terms of at least short-term benefits in terms of mood from CBT for substance use disorder. mood from CBT for substance use disorder.
Possible effects of participation Possible effects of participation in the study in the study There were significant improvements over There were significant improvements over time in the sample as a whole with regard time in the sample as a whole with regard to alcohol consumption, poly-drug use to alcohol consumption, poly-drug use and score on the aggregate substance use and score on the aggregate substance use index. Similar improvements in alcohol index. Similar improvements in alcohol use were reported for the sample as a whole use were reported for the sample as a whole in the study of psychiatric in-patients by in the study of psychiatric in-patients by Baker Baker et al et al (2002) . Hulse & Tait (2003 ) (2002 . Hulse & Tait (2003) also reported that, compared with matched also reported that, compared with matched controls, general hospital psychiatric incontrols, general hospital psychiatric inpatients (10% of whom had psychosis) patients (10% of whom had psychosis) who received either a motivational interwho received either a motivational interview or an information pack had signifiview or an information pack had significantly fewer mental health in-patient cantly fewer mental health in-patient episodes and showed other health benefits. episodes and showed other health benefits. The authors of that study suggested that The authors of that study suggested that ininformation together with the research process formation together with the research process (assessment, etc.) and psychiatric treatment (assessment, etc.) and psychiatric treatment may be sufficient to bring about change. may be sufficient to bring about change.
The need for alternative The need for alternative approaches approaches ) suggest that a more complex framework is needed which integrates plex framework is needed which integrates the available evidence into a coherent treatthe available evidence into a coherent treatment and research strategy. A stepped-care ment and research strategy. A stepped-care approach to treatment is one such frameapproach to treatment is one such framework, within which a series of tiered interwork, within which a series of tiered interventions are applied, with less intensive ventions are applied, with less intensive treatments being offered first, and more treatments being offered first, and more intensive targeted treatments being made intensive targeted treatments being made available contingent on the client's response available contingent on the client's response to the previous tier of treatment (Schippers to the previous tier of treatment (Schippers et al et al, 2002; Baker & Dawe, 2005) . (2001) was 22 sessions. Clearly, this challenging client group is able to engage challenging client group is able to engage in CBT and appears to derive benefit from in CBT and appears to derive benefit from it. By examining changes in the percentage it. By examining changes in the percentage of participants who remain above the initial of participants who remain above the initial intervention thresholds for substance use intervention thresholds for substance use (Table 3) , we can also gain insight into (Table 3) , we can also gain insight into the intensity of interventions that may be the intensity of interventions that may be required. For example, in the control group required. For example, in the control group more than two-thirds of those who met the more than two-thirds of those who met the intervention threshold criteria for alcohol intervention threshold criteria for alcohol or amphetamine use were already below or amphetamine use were already below those thresholds at the 15-week follow-up. those thresholds at the 15-week follow-up. Such findings reinforce the available Such findings reinforce the available research evidence which suggests that even research evidence which suggests that even minimal 'control' interventions (including minimal 'control' interventions (including assessment alone) can result in significant assessment alone) can result in significant changes. For some people, giving brief changes. For some people, giving brief advice within the context of ongoing assessadvice within the context of ongoing assessment and monitoring may be sufficient to ment and monitoring may be sufficient to stimulate the initiation of changes in life stimulate the initiation of changes in life circumstances. For others, specific therapy circumstances. For others, specific therapy programmes may be required. For example, programmes may be required. For example, in both the present study and our previous in both the present study and our previous study of psychiatric in-patients (Baker study of psychiatric in-patients (Baker et et al al, 2002) , more than 50% of cannabis users , 2002), more than 50% of cannabis users remained above the intervention threshold remained above the intervention threshold at the 12-month follow-up. at the 12-month follow-up.
Limitations Limitations
Finally, there are several study limitations Finally, there are several study limitations that need to be considered. that need to be considered.
It is acknowledged that there are several It is acknowledged that there are several different analytical strategies for assessing different analytical strategies for assessing change, each with its own particular advanchange, each with its own particular advantages and disadvantages, ranging from tages and disadvantages, ranging from simple change scores (e.g. paired simple change scores (e.g. paired t t-tests or -tests or repeated-measures ANOVAs) and other repeated-measures ANOVAs) and other more complex linear combinations (e.g. more complex linear combinations (e.g. polynomial trend contrasts) to analyses of polynomial trend contrasts) to analyses of covariance (ANCOVAs) in which, for excovariance (ANCOVAs) in which, for example, baseline scores are controlled when ample, baseline scores are controlled when assessing differences at follow-up (e.g. assessing differences at follow-up (e.g. Vickers & Altman, 2001 ). On the one Vickers & Altman, 2001 ). On the one hand, analyses that are based on traditional hand, analyses that are based on traditional change scores may ignore variance (in change scores may ignore variance (in change) that is associated with baseline change) that is associated with baseline levels, leading to treatment estimates that levels, leading to treatment estimates that have higher variability, in essence valuing have higher variability, in essence valuing one unit of change as the same across the one unit of change as the same across the full range of scores. On the other hand, full range of scores. On the other hand, when baseline differences are real (e.g. when baseline differences are real (e.g. naturally occurring groups), ANCOVAs naturally occurring groups), ANCOVAs may introduce directional bias, magnifying may introduce directional bias, magnifying post-baseline differences in one direction post-baseline differences in one direction and masking those in the other (Jamieson, and masking those in the other (Jamieson, 1999 (Jamieson, , 2004 . However, it is clear that deci-1999, 2004) . However, it is clear that decisions about the basic choice of analysis sions about the basic choice of analysis strategy should be made without reference strategy should be made without reference to the data collected (Jamieson, 1999) . In to the data collected (Jamieson, 1999) . In the present study, we opted for a traditional the present study, we opted for a traditional score-change-based approach, in the form score-change-based approach, in the form of planned comparisons between blocks of of planned comparisons between blocks of assessment time points from repeatedassessment time points from repeatedmeasures ANOVAs, where the primary measures ANOVAs, where the primary focus is on group focus is on group6 6time interaction time interaction comparisons. We also planned and concomparisons. We also planned and conducted preliminary baseline analyses of ducted preliminary baseline analyses of key (non-outcome) variables to determine key (non-outcome) variables to determine their likely suitability as conventional their likely suitability as conventional covariates. In this instance there were no covariates. In this instance there were no significant differences between the treatsignificant differences between the treatment ment and control groups with regard to key and control groups with regard to key socio-demographic or clinical characteristics socio-demographic or clinical characteristics (e.g. age, gender, level of education, marital (e.g. age, gender, level of education, marital status, illness onset or course, family history), status, illness onset or course, family history), and therefore no covariates were used. and therefore no covariates were used.
In circumstances such as those of the In circumstances such as those of the present study, where there are several posspresent study, where there are several possible bases for study entry (e.g. separate ible bases for study entry (e.g. separate thresholds for alcohol, cannabis and amthresholds for alcohol, cannabis and amphetamine use) and a range of outcomes phetamine use) and a range of outcomes of interest (e.g. substance use, symptomaof interest (e.g. substance use, symptomatology, general functioning), it becomes tology, general functioning), it becomes increasingly difficult to assume that postincreasingly difficult to assume that postrandomisation baseline differences between randomisation baseline differences between groups (across all of these outcome meagroups (across all of these outcome measures) are essentially caused by measuresures) are essentially caused by measurement error (i.e. they are not real), and are ment error (i.e. they are not real), and are consequently appropriate for inclusion in an consequently appropriate for inclusion in an ANCOVA-based strategy for assessing ANCOVA-based strategy for assessing change. One solution might have been to change. One solution might have been to use a complex, stratified randomisation prouse a complex, stratified randomisation procedure, taking account of baseline levels cedure, taking account of baseline levels across all (or most) of the key outcome variacross all (or most) of the key outcome variables when making initial group allocations, ables when making initial group allocations, but this was not done in the present study. but this was not done in the present study.
The present study was primarily conThe present study was primarily concerned with treatment efficacy -that is, cerned with treatment efficacy -that is, whether or not the actual treatments whether or not the actual treatments received were associated with the desired received were associated with the desired outcomes among the individuals who outcomes among the individuals who completed the study, while noting and/or completed the study, while noting and/or adjusting for any observed or likely recruitadjusting for any observed or likely recruitment, allocation or participation bias. ment, allocation or participation bias. Arguably, treatment efficacy needs to be Arguably, treatment efficacy needs to be demonstrated first, followed by attempts demonstrated first, followed by attempts to optimise treatment implementation and to optimise treatment implementation and effectiveness in real-world settings. Howeffectiveness in real-world settings. However, to facilitate comparison with other ever, to facilitate comparison with other RCTs, we also conducted a parallel series RCTs, we also conducted a parallel series of traditional intention-to-treat (ITT) or of traditional intention-to-treat (ITT) or programme-effectiveness analyses (Wright programme-effectiveness analyses (Wright & Sim, 2003) . For these analyses, missing & Sim, 2003) . For these analyses, missing follow-up data were imputed by carrying follow-up data were imputed by carrying forward the last available observation. forward the last available observation.
We did not evaluate the psychometric We did not evaluate the psychometric properties of the key self-report or cliniproperties of the key self-report or clinician-rated measures within the present cian-rated measures within the present study sample (in particular interrater reliastudy sample (in particular interrater reliability). However, the OTI has features simibility). However, the OTI has features similar to those of other structured interviews, lar to those of other structured interviews, and has been found to have acceptable valand has been found to have acceptable validity (Darke idity (Darke et al et al, 1992) , while the BPRS , 1992), while the BPRS (Ventura (Ventura et al et al, 1993) and the BDI (Beck , 1993 ) and the BDI (Beck et et al al, 1988) have well-established properties.
, 1988) have well-established properties. Likewise, interrater reliability on the GAF Likewise, interrater reliability on the GAF was not measured, but it has was not measured, but it has been been documented by Startup documented by Startup et al et al (2002) and (2002) and found to be satisfactory. Similarly, there found to be satisfactory. Similarly, there was no formal assessment of breaks in was no formal assessment of breaks in masking. However, this was unlikely to masking. However, this was unlikely to have been a problem, as the clinicians have been a problem, as the clinicians who conducted the follow-up interviews rewho conducted the follow-up interviews reported that the participants appreciated the ported that the participants appreciated the importance of the request not to disclose importance of the request not to disclose their group allocation. The absence of a their group allocation. The absence of a supportive counselling or other non-specific supportive counselling or other non-specific control condition means that we cannot decontrol condition means that we cannot determine the extent to which any of the bentermine the extent to which any of the benefits were primarily a result of contact with efits were primarily a result of contact with a therapist. Furthermore, the therapy sesa therapist. Furthermore, the therapy sessions were not tape-recorded. However, a sions were not tape-recorded. However, a therapist checklist was completed at the therapist checklist was completed at the end of each treatment session. Direct ratend of each treatment session. Direct ratings of therapist adherence to the treatment ings of therapist adherence to the treatment manual should probably be included in manual should probably be included in future studies. Another area of possible future studies. Another area of possible concern is the representativeness of the concern is the representativeness of the sample. Relative to the study by Barrowsample. Relative to the study by Barrowclough clough et al et al (2001) , there were differences (2001), there were differences in the level of current functioning and in in the level of current functioning and in the nature and duration of the interventhe nature and duration of the interventions. However, despite differences in samtions. However, despite differences in sampling strategies and in the interventions that pling strategies and in the interventions that were delivered, there were broad similariwere delivered, there were broad similarities in the findings. Recruitment and retenties in the findings. Recruitment and retention of sufficiently large samples are always tion of sufficiently large samples are always a methodological concern. In addition, stua methodological concern. In addition, studies such as the present one and that of dies such as the present one and that of Barrowclough Barrowclough et al et al (2001) typically have (2001) typically have lower statistical power to detect differences lower statistical power to detect differences among users of particular substances than among users of particular substances than overall treatment effects on aggregate overall treatment effects on aggregate indexes of substance use, as is illustrated by indexes of substance use, as is illustrated by the uncertainties associated with the small the uncertainties associated with the small numbers of regular amphetamine users in numbers of regular amphetamine users in the present study. Finally, although we the present study. Finally, although we would encourage clinicians to use the treatwould encourage clinicians to use the treatment manual prepared for this study (Baker ment manual prepared for this study (Baker et al et al, 2004) , further research is needed to de-, 2004) , further research is needed to develop more effective motivational interviewvelop more effective motivational interviewing/CBT interventions for people with ing/CBT interventions for people with psychosis who are heavy users of substances, psychosis who are heavy users of substances, especially cannabis, and to extend these interespecially cannabis, and to extend these interventions to young people with mental health ventions to young people with mental health problems who have not yet progressed to problems who have not yet progressed to substance dependence. substance dependence. 
Factor structure and differential validity of the Expanded Factor structure and differential validity of the Expanded Brief Psychiatric Rating Scale. Brief Psychiatric Rating Scale. Assessment Assessment, , 11 11, 177^187. , 177^187. Over two-thirds of the present sample of people with psychotic disorders who were assigned to a motivational interviewing/CBT intervention for substance use were assigned to a motivational interviewing/CBT intervention for substance use attended all 10 treatment sessions. attended all 10 treatment sessions.
& & There is a short-term improvement in depression and a similar trend with regard
There is a short-term improvement in depression and a similar trend with regard to cannabis use among individuals who receive a motivational interviewing/CBT to cannabis use among individuals who receive a motivational interviewing/CBT intervention, together with improved general functioning after12 months.There is no intervention, together with improved general functioning after12 months.There is no differential beneficial effect of the intervention on substance use after 12 months, differential beneficial effect of the intervention on substance use after 12 months, except for a potentially clinically important effect on amphetamine use. except for a potentially clinically important effect on amphetamine use. Assessment and brief advice in the context of ongoing monitoring appear to have an overall beneficial effect, particularly on alcohol consumption, prompting calls for a an overall beneficial effect, particularly on alcohol consumption, prompting calls for a consideration of alternative approaches such as stepped care. consideration of alternative approaches such as stepped care.
LIMITATIONS LIMITATIONS
& & There was no control for the extra therapy time associated with the motivational There was no control for the extra therapy time associated with the motivational interviewing/CBT intervention, the therapy sessions were not recorded, and interviewing/CBT intervention, the therapy sessions were not recorded, and interrater reliability was not assessed. interrater reliability was not assessed. The relatively high levels of functioning in the present sample may have compromised the generalisability of the study findings. compromised the generalisability of the study findings.
